Sukumar Nagendran - Director, Taysha Gene Therapies, Inc

As of June 22, 2022


What is Sukumar Nagendran's Net Worth?

The current estimated net worth of Taysha Gene Therapies, Inc's Director, Sukumar Nagendran, is estimated to be about $2.13M . Sukumar Nagendran owns about 29,226 units of Taysha Gene Therapies, Inc common stock. In the last 2 years at Taysha Gene Therapies, Inc, Sukumar Nagendran has sold an estimated value of $0 worth.

What is Sukumar Nagendran's Past Insider Trading?

Sukumar Nagendran's largest purchase order was 10,000 units , worth over $80.1K on February 3, 2022. In total, Sukumar Nagendran has made about 5 transactions over 2 years of their time at Taysha Gene Therapies, Inc. Sukumar Nagendran usually trades in September and June, with the busiest year in 2020 and 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Sukumar Nagendran's' Mailing Address?

  • Mailing address is C/o Avexis, Inc., 2275 Half Day Road Suite 160 Bannockburn IL 60015 IL

What are Taysha Gene Therapies, Inc's Past Insider Trades?

Taysha Gene Therapies, Inc's most recent insider trade came on February 4, 2022 by Paul Manning who bought 201,602 units worth $1.57M . In the last year, insiders at Taysha Gene Therapies, Inc have sold an estimated value of $2.34M and bought an estimated value of $2.76M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Paul Manning, Director,  Suyash Prasad, CMO and Head R&D,  and Kamran Alam, Chief Financial Officer .

Taysha Gene Therapies, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1